Exponent (EXPO) vs Genpact (G)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
Exponent (EXPO) has outperformed Genpact (G) over the past year, gaining 4.0% versus a loss of 17.3%. Over five years, G leads with a -32.5% price change compared with -37.8% for EXPO. Genpact is the larger company by market cap ($5.80 billion vs $3.32 billion), about 1.7 times the size.
On valuation, Genpact trades at a lower forward P/E (7.7x vs 25.7x for Exponent). Genpact offers the higher dividend yield (2.06% vs 1.75%). Exponent converts more of its revenue into profit, with a net margin of 18.2% versus 10.9%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | EXPO | G |
|---|---|---|
| Share price | $69.78 | $34.67 |
| Market cap | $3.32B | $5.80B |
| 1-day change | +1.20% | +3.03% |
| YTD return | -0.73% | -28.07% |
| 1-year return | +3.98% | -17.32% |
| 5-year return | -37.84% | -32.47% |
| P/E ratio (TTM) | 31.29 | 10.32 |
| Forward P/E | 25.65 | 7.68 |
| EPS (TTM) | $2.23 | $3.36 |
| Dividend yield | 1.75% | 2.06% |
| Annual dividend | $1.22 | $0.715 |
| Revenue (latest FY) | $582.01M | $5.08B |
| Revenue growth (YoY) | +4.21% | +6.56% |
| Net income (latest FY) | $106.01M | $552.49M |
| Gross margin | — | 36.04% |
| Operating margin | 20.58% | 14.77% |
| Net margin | 18.21% | 10.88% |
| 52-week high | $81.95 | $48.64 |
| 52-week low | $51.91 | $26.85 |
| Distance from 52-week high | -14.85% | -28.72% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +20.38% | +21.66% |
| Average volume | 510.85K | 2.18M |
| Shares outstanding | 47.55M | 167.23M |
| Employees | 1,012 | 141,000 |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Industry | Professional Services | Professional Services |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- EXPO has outperformed G by 21.3 percentage points over the past year.
- Exponent trades at a higher earnings multiple (31.3x vs 10.3x trailing P/E).
- Exponent is more profitable, keeping 18.2 cents of every revenue dollar as net income versus 10.9 cents for Genpact.
About Exponent
EXPO stock →Exponent, Inc., together with its subsidiaries, operates as a science and engineering consulting company in the United States and internationally. The company operates in two segments, Engineering and Other Scientific, and Environmental and Health.
Consumer Discretionary · Professional Services · 1,012 employees
About Genpact
G stock →Genpact Limited, an agentic and advanced technology solutions company, provides digital transformation, business process management, technology, data, analytics, and artificial intelligence (AI) services to enterprises in India, the rest of Asia, North and Latin America, and Europe. Its Financial Services segment offers customer onboarding, customer service, collections, retail and commercial loan operations, payment operations, mortgage origination and servicing, compliance, wealth management, capital market operations support, financial crime and risk management, proprietary insurance policy suite, underwriting support, new business processing, policy administration, customer, claims management, catastrophe and exposure/risk modeling, actuarial services, end-to-end third-party administration for property and casualty claims, and technology services.
Consumer Discretionary · Professional Services · 141,000 employees
EXPO vs G FAQ
Which is bigger, Exponent or Genpact?
Genpact (G) is larger, with a market capitalization of $5.80B compared with $3.32B for Exponent (EXPO).
Which stock has performed better over the past year, EXPO or G?
EXPO returned +3.98% over the past 12 months, compared with -17.32% for G (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, EXPO or G?
G has the lower trailing P/E at 10.3, versus 31.3 for EXPO. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Exponent or Genpact?
Genpact has the higher yield at 2.06%, compared with 1.75% for Exponent.
Are Exponent and Genpact in the same industry?
Yes. Both are classified in the Professional Services industry within the Consumer Discretionary sector.